Boldenone Undecylenate Formula: Q9H2602
Molecular Weight (base): 286.4132 gm/mol Molecular Weight (ester): 186.2936 gm/mol Active life: 15 days Detection time: up to 5 months Anabolic/Androgenic ratio: 100:50
BOLD 300® is a steroid compound that is described chemically as 1,4- androstadienc-3-one, 17b-ol.
BOLD 300® is a 300 mg per ml of Boldenone Undecylenate, Miglyol 840, Ethyl oleate.
Benzyl benzoate, Benzyl alcohol which is an oily solution for intramuscular injection. BOLD 300® is designed to release Boldenone slowly from the injection site. BOLD 300® is an anabolic steroid possessing anabolic properties with moderate androgenic activity. Anabolic and androgenic agents are widely used in the treatment of catabolic processes where accelerated strength and muscular development are indicated.
Boldenone Undecylenate has been used as an extremely powerful long acting anabolic agent which has a rapid onset of action. This is advantageous and is preferred over frequent oral dosing or even repeated injections in veterinary practice.
Anabolic agents are related to the male sex hormones, but each varies in its anabolic and androgenic effect. Compounds such as methyltestosterone have anabolic activity, but with prolonged use, animals develop marked androgenic activity which makes these compounds unsuitablefor prolonged.
Anabolic steroids suppress the gonadotropic functions of the pituitary and may exert a direct effect upon the testes. During exogenous administration of anabolic androgens, endogenous testosterone release is inhibited through inhibition of pituitary luteinizing hormone (LH). At large doses, spermatogenesis may be suppressed through feedback inhibition of pituitary follicle- stimulating hormone (FSH).
Pharmacological studies conducted in laboratory animals to evaluate the pharmacological activity characterized BOLD 300® as having distinct anabolic properties together with a certain degree of androgenic activity. It does not have marked antigonadotropic properties nor does it produce any clear-cut effects on the endometrium, conditions that are commonly observed when similar substances are used.
In clinical trials, at the recommended dosage, BOLD 300® had a marked anabolic effect in debilitated horses; appetite improved, vigor increased and improvement was noted in hair coat, musculature and strength. This would be expected with an anabolic agent such as BOLD 300®, particularly where there had been marked tissue breakdown associated with disease, prolonged anorexia or overwork.
INDICATIONS AND USAGE:
BOLD 300® is indicated as an alternate or adjunctive therapy in patients for the promotion of weight gain following weight loss and/or muscular atrophy associated with extensive surgery, chronic infections, long term hospitalization, or severe trauma.
BOLD 300® should be considered only as an adjunctive therapy togetherwith otherandrogenic medications.
Males: BOLD 300® is indicated for increasing muscular mass, hardness and strength with low water retention and low estrogenic activity, as well as increasing the metabolic rate.
Females: Women should take caution.
Horses: BOLD 300® is recommended as an aid for treating debilitated horses when an improvement in weight, hair coat or general physical condition is desired. Debilitation often follows disease or may occur following overwork and overexertion. BOLD 300® improves the general state of debilitated horses, thus aiding in correcting weight losses and improving appetite. It is not a substitute for a well-balanced diet. Optimal results can be expected only when good management and feeding practices are utilized.
For increased RBC: in severe anemic patients where first-line therapy is contraindicated.
For promotion of increased appetite in patients: with appetite limited intake.